UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Learn Which Crypto Assets Are Considered Low Risk and how to compare safety factors. This intro helps you screen assets with prudent criteria.
27,883 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
SpaceX’s public debut could bring huge hype and big risks for everyday investors. This guide breaks down the mechanic...
As markets wobble, monthly dividend strategies attract investors seeking steady cash flow. A hypothetical $25,000 int...
Marqeta has signaled a potential reverse stock split coming, a move often used by firms facing listing or liquidity c...
The 2026 software stock sell-off has traders buzzing, even as many companies post solid results. Is AI disruption fea...
Are there real opportunities hiding in plain sight? This guide explains why the market may be getting these stocks wr...
A large block sale can shake a stock, but it isn’t a crush course in risk. This guide explains what investors should ...
SoFi stock down more this year, yet chief executive Anthony Noto has been buying shares. This article breaks down wha...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
When a software company posts strong results and outlines a confident path forward, investors often push the stock hi...
On Mar. 5, oil surged and AI export worries weighed on tech names, sending the S&P 500, Nasdaq, and Dow lower. This a...
Looking to invest with a decade-long horizon? Here are three tech stocks to buy and hold, backed by strong moats, cas...